News
BioMarin downgraded to Hold amid rising competition, pipeline concerns, and ambitious growth targets, despite solid Q1 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback